Plain-English translation of NCT06408337 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing BIOCLEFT, a tissue engineered from your own mouth cells, to see if it can help improve how well the palate heals after cleft palate surgery. Researchers will compare children who receive this new treatment alongside standard surgery to children who have standard surgery alone. The goal is to understand whether this medication is safe and effective.
Standard cleft palate surgery works well, but healing and tissue growth can sometimes be unpredictable. This trial exists to see whether adding this laboratory-grown tissue substitute can help improve the quality of healing and reduce complications.
You likely qualify if…
You likely don't qualify if…
If you join, you'll have 2 visits before surgery, then receive either the new tissue treatment plus standard cleft palate surgery, or standard surgery alone (decided by random assignment). After surgery, you'll return for 9 follow-up visits over 24 months so doctors can check how well you're healing and whether the treatment is working. The study involves regular check-ups but no additional procedures beyond standard cleft care.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Spain